News for hackers. Stuff that matters.
Re:The financial cost of not knowing things by danieltillett on Saturday May 12, 2018 @04:31AM (#17053066)
Just to be a pedant the FDA doesn't consider the value of a drug to society, just if it is safe and effective. It is up to the pharmaceutical company to decide if it is worth developing and selling a new drug.

One thing the FDA doesn't consider that I think they should is the cost of not approving a drug. Safety and effectiveness is not black and white when faced with uncertainly.

Re:The financial cost of not knowing things by andyferris on Saturday May 12, 2018 @04:37AM (#17053076)
A agree, that's totally true. That "exercise" was just my thought experiment about what might be for "the greater good" (whatever that might mean, precisely).
Re:The financial cost of not knowing things by nordsieck on Saturday May 12, 2018 @05:28AM (#17053219)
> One thing the FDA doesn't consider that I think they should is the cost of not approving a drug. Safety and effectiveness is not black and white when faced with uncertainly.

There is an excellent lecture by Richard Epstein on this topic [0].

tldr: The FDA doesn't allow pre-stage 3 access to drugs because it would, in part, reduce demand to be part of stage 3 trials. However, it's much more complicated than that.

[0] Chicago's Best Ideas: "Clinical Trials on Trial: How Should the FDA Do Its Job?" https://www.youtube.com/watch?v=IEhzoh86N9M